Achromic superficial spreading melanoma accidentally treated with imiquimod

Acta Dermato-Venereologica

Volumn 92, Issue 1, 2012, Pages 107-108

  Zattra, Edoardo ^a   Salmaso, Roberto ^a   Tonin, Elena ^b   Alaibac, Mauro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ADULT; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CANCER SURGERY; CASE REPORT; EPILUMINESCENCE MICROSCOPY; EXCISION; FEMALE; HISTOPATHOLOGY; HUMAN; LETTER; MELANOMA; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MEDICATION ERRORS; MELANOMA, AMELANOTIC; SKIN NEOPLASMS;

EID: 84855227285     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1166     Document Type: Letter

References (5)

1. Gupta AK, Cherman AM, Tyring SK. Viral and nonviral uses of imiquimod: a review. J Cutan Med Surg 2004; 8: 338-352.
2. Fisher GH. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease. Arch Dermatol 2003; 139: 945-947.
3. Missall TA, Hurley MY, Fosko SW. Lentiginous melanoma in situ treatment with topical imiquimod: need for individualized regimens. Arch Dermatol 2010; 146: 1309-1310.
4. Liu W, Dowling JP, Murray WK, McArthur GA, Thompson JF, Wolfe R, Kelly JW. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol 2006; 142: 1551-1558.
5. Woodmansee CS, McCall MW. Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod. Dermatol Surg 2009; 35: 1286-1289.